Skip to main content

Table 1 The clinical characteristic information of the HCC patients in TCGA and ICGC

From: DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination

Characteristics TCGA (%) ICGC (%)
Age
 < 60 177 (47.32) 50 (27.59)
 ≥ 60 196 (52.41) 210 (72.41)
NA 1 (0.27)  
Gender
 Male 253 (67.65) 192 (73.71)
 Female 121 (32.35) 68 (26.29)
Survival status
 Alive 238 (63.64) 214 (81.47)
 Dead 130 (34.76) 46 (18.53)
 NA 6 (1.60)  
Stage
 I 173 (46.26) 40 (15.52)
 II 87 (23.26) 117 (45.69)
 III 85 (22.73) 80 (30.60)
 IV 5 (1.34) 23 (8.19)
 NA 24 (6.42)  
Histological grade
 G1 55 (14.71) NA
 G2 178 (47.59) NA
 G3 124 (33.16) NA
 G4 12 (3.21) NA
 NA 5 (1.34)  
T classification
 T1 183 (48.93) NA
 T2 95 (25.40) NA
 T3 80 (21.39) NA
 T4 13 (3.48) NA
 NA 3 (0.80)  
N classification
 N0 254 (67.91) NA
 N1 4 (1.07) NA
 NX 115 (30.75) NA
 NA 1 (0.27)  
M classification
 M0 268 (71.66) NA
 M1 4 (1.07) NA
 MX 102 (27.27)  
  1. NA not available